<DOC>
	<DOCNO>NCT02580929</DOCNO>
	<brief_summary>This study aim evaluate effectiveness radiotherapy surgery high-risk relapse hepatocellular cancer patient .</brief_summary>
	<brief_title>Clinical Study Effectiveness Radiotherapy Before Surgery High-risk Relapse Hepatocellular Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Clinical diagnosis HCC 2 . In high risk recurrence HCC still endure palliative resection 3 . KPS score &gt; 90 4 . With ChildPugh Class A liver funcion , serum bilirubin &lt; 1.5*normal maxism ; ALT AST &lt; 1.5*normal maxism ; normal creatinine urea nitrogen ; WBC &gt; 4×109/L , Hb &gt; 110g/L , PLT &gt; 90X109/L . 5 . Have sign inform consent 1 . HCC operate 2 . With ChildPugh Class B/C 3 . Have organ cancer , exclude curative nonmelanotic skin cancer carcinoma situ cervix 4 . Have severe disease 5 . With active hepatitis 6 . Have accept local radiation therapy hospital 7 . KPS scores≤70 8 . Tumor edge define 9 . Have severe cirrhosis complication 10 . Intensity modulate radiation therapy reach require dose 11 . Can cooperate 12 . Lactant pregnant 13 . Cannnot inform</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>General Surgery</keyword>
</DOC>